Unless otherwise noted, speakers have nothing to disclose.

Moderators

Farhood Farjah, MD
Svetlana Kotova, MD

Presentations

1. Incidence, Timing, and Causes of Death Among Patients Who Underwent Lobectomy forStage IA Lung Cancer in the National Lung Screening Trial
   Alexandra Potter, BS
    
2. A pH-activatable near-infrared nanoprobe labels diverse histologic subtypes of human lung cancer during resection
   Gregory Thomas Kennedy
    
3. Segmentectomy for Less Than 2 cm Non-Small-Cell Lung Cancer with Visceral Pleural Invasion is Associated with Similar Survival as Lobectomy
   Camille Mathey-Andrews, MD
    
4. Summary of JCOG0802 & CALGB 140503 trials
   Nasser Altorki, MD
    
5. Panel Discussion/Q&A
   David Tom Cooke, MD
   Disclosure: DaVinci Intuitive Surgical: Food and travel costs (Ongoing)
   
   Betty C. Tong, MD
   Disclosure: Medtronic: Consultant (Terminated)
   
   Janet Edwards, MD, MPH
   
   Nasser Altorki, MD